Market Closed -
Nyse
04:00:02 2024-05-10 pm EDT
|
5-day change
|
1st Jan Change
|
5.39
USD
|
-4.09%
|
|
+6.94%
|
-22.45%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
4,505
|
1,117
|
1,175
|
917.5
|
-
|
-
|
Enterprise Value (EV)
1 |
4,310
|
957.2
|
1,175
|
667.9
|
611.9
|
561.2
|
P/E ratio
|
-459
x
|
61.2
x
|
57.9
x
|
93.7
x
|
45.6
x
|
34.8
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
10.7
x
|
2.21
x
|
2.15
x
|
1.68
x
|
1.61
x
|
1.53
x
|
EV / Revenue
|
10.3
x
|
1.89
x
|
2.15
x
|
1.22
x
|
1.08
x
|
0.94
x
|
EV / EBITDA
|
40.9
x
|
11
x
|
13.7
x
|
12
x
|
8.51
x
|
7.23
x
|
EV / FCF
|
67.6
x
|
-23.5
x
|
-
|
15.7
x
|
12.2
x
|
19.1
x
|
FCF Yield
|
1.48%
|
-4.25%
|
-
|
6.38%
|
8.2%
|
5.23%
|
Price to Book
|
17.9
x
|
4.1
x
|
-
|
2.16
x
|
1.92
x
|
1.71
x
|
Nbr of stocks (in thousands)
|
163,457
|
165,963
|
169,135
|
170,228
|
-
|
-
|
Reference price
2 |
27.56
|
6.730
|
6.950
|
5.390
|
5.390
|
5.390
|
Announcement Date
|
3/8/22
|
2/28/23
|
2/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
419.6
|
505.8
|
545.6
|
545.3
|
568.5
|
599.2
|
EBITDA
1 |
105.2
|
87.25
|
86
|
55.49
|
71.91
|
77.63
|
EBIT
1 |
10.98
|
37.67
|
34.04
|
10.13
|
26.11
|
35.1
|
Operating Margin
|
2.62%
|
7.45%
|
6.24%
|
1.86%
|
4.59%
|
5.86%
|
Earnings before Tax (EBT)
1 |
9.859
|
38.73
|
40.81
|
18.8
|
35.07
|
39.58
|
Net income
1 |
-9.556
|
21.19
|
22.64
|
11.22
|
22.76
|
28.81
|
Net margin
|
-2.28%
|
4.19%
|
4.15%
|
2.06%
|
4%
|
4.81%
|
EPS
2 |
-0.0600
|
0.1100
|
0.1200
|
0.0575
|
0.1183
|
0.1550
|
Free Cash Flow
1 |
63.72
|
-40.68
|
-
|
42.64
|
50.16
|
29.35
|
FCF margin
|
15.19%
|
-8.04%
|
-
|
7.82%
|
8.82%
|
4.9%
|
FCF Conversion (EBITDA)
|
60.55%
|
-
|
-
|
76.85%
|
69.75%
|
37.81%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
380.15%
|
220.33%
|
101.87%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/8/22
|
2/28/23
|
2/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
128.7
|
110.1
|
122.2
|
128.6
|
144.9
|
120.2
|
138.1
|
142.4
|
144.9
|
119.3
|
142.3
|
136.3
|
146.9
|
122.6
|
149.5
|
EBITDA
1 |
31.9
|
24.98
|
21.48
|
21.02
|
19.76
|
16.08
|
18.9
|
24.42
|
26.6
|
12.99
|
12.11
|
11.41
|
18.42
|
13.63
|
19.3
|
EBIT
1 |
16.43
|
13.74
|
9.451
|
11.21
|
3.26
|
3.297
|
6.566
|
9.954
|
14.23
|
-
|
-1.141
|
4
|
7.444
|
1.2
|
8.2
|
Operating Margin
|
12.77%
|
12.48%
|
7.73%
|
8.72%
|
2.25%
|
2.74%
|
4.75%
|
6.99%
|
9.82%
|
-
|
-0.8%
|
2.94%
|
5.07%
|
0.98%
|
5.49%
|
Earnings before Tax (EBT)
1 |
16.31
|
13.75
|
9.521
|
11.82
|
3.638
|
4.368
|
8.083
|
11.85
|
16.51
|
3.28
|
-1.612
|
3.55
|
8.675
|
2.433
|
9.2
|
Net income
1 |
12.6
|
8.899
|
4.852
|
4.044
|
3.391
|
1.909
|
4.582
|
6.146
|
10
|
1.435
|
-1.098
|
2.292
|
5.43
|
1.921
|
6.191
|
Net margin
|
9.79%
|
8.08%
|
3.97%
|
3.14%
|
2.34%
|
1.59%
|
3.32%
|
4.32%
|
6.9%
|
1.2%
|
-0.77%
|
1.68%
|
3.7%
|
1.57%
|
4.14%
|
EPS
2 |
0.0600
|
0.0500
|
0.0300
|
0.0200
|
0.0200
|
0.0100
|
0.0200
|
0.0300
|
0.0500
|
0.0100
|
-0.0100
|
0.005000
|
0.0340
|
0.0100
|
0.0300
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/8/22
|
5/12/22
|
8/4/22
|
11/10/22
|
2/28/23
|
5/4/23
|
8/3/23
|
11/2/23
|
2/28/24
|
5/9/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
195
|
160
|
-
|
250
|
306
|
356
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
63.7
|
-40.7
|
-
|
42.6
|
50.2
|
29.3
|
ROE (net income / shareholders' equity)
|
-5.57%
|
7.66%
|
-
|
2.18%
|
4.39%
|
5.83%
|
ROA (Net income/ Total Assets)
|
-
|
6%
|
-
|
2.5%
|
3.9%
|
4.9%
|
Assets
1 |
-
|
353.4
|
-
|
448.7
|
583.7
|
587.9
|
Book Value Per Share
2 |
1.540
|
1.640
|
-
|
2.500
|
2.810
|
3.160
|
Cash Flow per Share
2 |
0.4200
|
-0.1900
|
-
|
0.2700
|
0.3500
|
-
|
Capex
1 |
2.71
|
5.35
|
-
|
17.5
|
11.5
|
19.5
|
Capex / Sales
|
0.65%
|
1.06%
|
-
|
3.21%
|
2.02%
|
3.25%
|
Announcement Date
|
3/8/22
|
2/28/23
|
2/28/24
|
-
|
-
|
-
|
Last Close Price
5.39
USD Average target price
5.688
USD Spread / Average Target +5.52% Consensus |
1st Jan change
|
Capi.
|
---|
| -22.45% | 918M | | +9.48% | 27.43B | | -28.65% | 3.18B | | -16.08% | 2.53B | | +19.05% | 2.49B | | +11.11% | 2.16B | | -4.24% | 2.03B | | +5.56% | 1.61B | | +2.70% | 1.31B | | +29.73% | 1.29B |
Medical Supplies
|